Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases


Creative Commons License

SİPAHİ O. R. , KAHRAMAN H., MERMER S., PULLUKÇU H. , TAŞBAKAN M. , ARDA B. , ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.23, ss.16-19, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.ijid.2014.01.027
  • Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
  • Sayfa Sayıları: ss.16-19

Özet

Background: Tigecycline is a relatively new glycylcycline antimicrobial, active in vitro against a variety of Gram-positive and Gram-negative organisms. In this study we evaluated the outcomes of spondylodiscitis cases treated with tigecycline-including therapies retrospectively.